In a new ICT article, Lightship Chief Medical Advisor Dr. Lindsay Van Pelt explores how reducing travel burden can help

We're excited to welcome DOR Research Accelerator to Lightship, marking our first California site and expanding our neuroscience and psychiatry

Lightship has appointed Gail Kang, MD, as a dedicated Principal Investigator, strengthening our ability to support neurology studies and expand

In a recent episode of SCRS Talks, Lightship COO Darcy Forman joins Jimmy Bechtel of the Society for Clinical Research

Lightship today announced the appointment of Lindsay Van Pelt, MD, as its new Chief Medical Advisor. Dr. Van Pelt will

Lightship announced that it has selected and implemented CRIO’s integrated eSource and site clinical trial management system (CTMS) to further

Lightship has acquired Veda Trials, a company specializing in end‑to‑end clinical operations delivered in community care settings. The acquisition strengthens

Lightship has relocated its headquarters to Research Triangle Park (RTP), North Carolina. The move strengthens day-to-day collaboration across the company’s

IGC Pharma announced the addition of Dominion Medical Associates to the Company's Phase 2 CALMA clinical trial evaluating IGC-AD1 for